Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α

Juliana O Toledo,1 Clayton F Moraes,2,3 Vinícius C Souza,2 Audrey C Tonet-Furioso,2 Luís CC Afonso,4 Cláudio Córdova,3 Otávio T Nóbrega1,2 1Graduate Program in Health Sciences, 2Graduate Program in Medical Sciences, University of Bra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Toledo JO, Moraes CF, Souza VC, Tonet-Furioso AC, Afonso LCC, Córdova C, Nóbrega OT
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/0107c04001df4372ba22560b172e907d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0107c04001df4372ba22560b172e907d
record_format dspace
spelling oai:doaj.org-article:0107c04001df4372ba22560b172e907d2021-12-02T01:40:08ZTailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α1178-1998https://doaj.org/article/0107c04001df4372ba22560b172e907d2015-01-01T00:00:00Zhttps://www.dovepress.com/tailored-antihypertensive-drug-therapy-prescribed-to-older-women-atten-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Juliana O Toledo,1 Clayton F Moraes,2,3 Vinícius C Souza,2 Audrey C Tonet-Furioso,2 Luís CC Afonso,4 Cláudio Córdova,3 Otávio T Nóbrega1,2 1Graduate Program in Health Sciences, 2Graduate Program in Medical Sciences, University of Brasília, Brasília, 3Graduate Program in Gerontology, Catholic University of Brasília, Brasília, 4Research Center in Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil Objective: To test the hypothesis that antihypertensive drug therapy produces anti-inflammatory effects in clinical practice, this study investigated circulating levels of selected proinflammatory mediators (interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α], and interferon-γ [INF-γ]) in response to multivariate drug directions for blood pressure (BP) control.Methods: Prospective study involving 110 hypertensive, community-dwelling older women with different metabolic disorders. A short-term BP-lowering drug therapy was conducted according to current Brazilian guidelines on hypertension, and basal cytokine levels were measured before and after intervention.Results: Interventions were found to represent current hypertension-management practices in Brazil and corresponded to a significant reduction in systolic and diastolic BP levels in a whole-group analysis, as well as when users and nonusers of the most common therapeutic classes were considered separately. Considering all patients, mean IL-6 and TNF-α levels showed a significant decrease in circulating concentrations (P<0.01) at the endpoint compared with baseline, whereas the mean INF-γ level was not significantly different from baseline values. In separate analyses, only users of antagonists of the renin–angiotensin system and users of diuretics exhibited the same significant treatment-induced reduction in serum IL-6 and TNF-α observed in the whole group.Conclusion: Our data demonstrates that a clinically guided antihypertensive treatment is effective in reversing the low-grade proinflammatory state of serum cytokines found in postmenopausal women and support extracardiac benefits from diuretics and renin–angiotensin system antagonists. Keywords: renin–angiotensin system, cytokine, hypertension, drug therapy, guidelines, inflammation Toledo JOMoraes CFSouza VCTonet-Furioso ACAfonso LCCCórdova CNóbrega OTDove Medical Pressarticlerenin-angiotensin systemcytokinehypertensiondrug therapyguidelinespolymorphism.GeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 209-215 (2015)
institution DOAJ
collection DOAJ
language EN
topic renin-angiotensin system
cytokine
hypertension
drug therapy
guidelines
polymorphism.
Geriatrics
RC952-954.6
spellingShingle renin-angiotensin system
cytokine
hypertension
drug therapy
guidelines
polymorphism.
Geriatrics
RC952-954.6
Toledo JO
Moraes CF
Souza VC
Tonet-Furioso AC
Afonso LCC
Córdova C
Nóbrega OT
Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
description Juliana O Toledo,1 Clayton F Moraes,2,3 Vinícius C Souza,2 Audrey C Tonet-Furioso,2 Luís CC Afonso,4 Cláudio Córdova,3 Otávio T Nóbrega1,2 1Graduate Program in Health Sciences, 2Graduate Program in Medical Sciences, University of Brasília, Brasília, 3Graduate Program in Gerontology, Catholic University of Brasília, Brasília, 4Research Center in Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil Objective: To test the hypothesis that antihypertensive drug therapy produces anti-inflammatory effects in clinical practice, this study investigated circulating levels of selected proinflammatory mediators (interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α], and interferon-γ [INF-γ]) in response to multivariate drug directions for blood pressure (BP) control.Methods: Prospective study involving 110 hypertensive, community-dwelling older women with different metabolic disorders. A short-term BP-lowering drug therapy was conducted according to current Brazilian guidelines on hypertension, and basal cytokine levels were measured before and after intervention.Results: Interventions were found to represent current hypertension-management practices in Brazil and corresponded to a significant reduction in systolic and diastolic BP levels in a whole-group analysis, as well as when users and nonusers of the most common therapeutic classes were considered separately. Considering all patients, mean IL-6 and TNF-α levels showed a significant decrease in circulating concentrations (P<0.01) at the endpoint compared with baseline, whereas the mean INF-γ level was not significantly different from baseline values. In separate analyses, only users of antagonists of the renin–angiotensin system and users of diuretics exhibited the same significant treatment-induced reduction in serum IL-6 and TNF-α observed in the whole group.Conclusion: Our data demonstrates that a clinically guided antihypertensive treatment is effective in reversing the low-grade proinflammatory state of serum cytokines found in postmenopausal women and support extracardiac benefits from diuretics and renin–angiotensin system antagonists. Keywords: renin–angiotensin system, cytokine, hypertension, drug therapy, guidelines, inflammation 
format article
author Toledo JO
Moraes CF
Souza VC
Tonet-Furioso AC
Afonso LCC
Córdova C
Nóbrega OT
author_facet Toledo JO
Moraes CF
Souza VC
Tonet-Furioso AC
Afonso LCC
Córdova C
Nóbrega OT
author_sort Toledo JO
title Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
title_short Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
title_full Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
title_fullStr Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
title_full_unstemmed Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
title_sort tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/0107c04001df4372ba22560b172e907d
work_keys_str_mv AT toledojo tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT moraescf tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT souzavc tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT tonetfuriosoac tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT afonsolcc tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT cordovac tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
AT nobregaot tailoredantihypertensivedrugtherapyprescribedtoolderwomenattenuatescirculatinglevelsofinterleukin6andtumornecrosisfactoralpha
_version_ 1718402937079726080